Treatment of Abdominal Desmoplastic Small Round Cell Tumor Induces Acute Myeloid Leukemia-M5: A Case Report and Literature Review

References

• Lettieri CK, Garcia-Filion P, Hingorani P. Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results database. J Cancer Epidemiol. 2014;2014:680126. doi:10.1155/2014/680126
   PubMedGoogle Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544
   PubMed Web of Science ®Google Scholar
• Kayser S, Dohner K, Krauter J, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 2011;117(7):2137–2145. doi:10.1182/blood-2010-08-301713
   PubMed Web of Science ®Google Scholar
• Granfeldt OL, Medeiros BC, Sengelov H, et al. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: a National Population-Based Cohort Study. J Clin Oncol. 2015;33(31):3641–3649. doi:10.1200/JCO.2014.60.0890
   PubMed Web of Science ®Google Scholar
• Hulegardh E, Nilsson C, Lazarevic V, et al. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry. Am J Hematol. 2015;90(3):208–214. doi:10.1002/ajh.23908
   PubMed Web of Science ®Google Scholar
• Xiang T, Zhang SY, Wang SS, Fei RS, Li H. A nationwide analysis of desmoplastic small round cell tumor. Medicine. 2020;99(30):e21337. doi:10.1097/MD.0000000000021337
   PubMed Web of Science ®Google Scholar
• Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol. 2003;16(3):229–235. doi:10.1097/01.MP.0000056630.76035.F3
   PubMed Web of Science ®Google Scholar
• Liu J, Nau MM, Yeh JC, Allegra CJ, Chu E, Wright JJ. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Clin Cancer Res. 2000;6(9):3522–3529.
   PubMed Web of Science ®Google Scholar
• Lal DR, Su WT, Wolden SL, Loh KC, Modak S, La Quaglia MP. Results of multimodal treatment for desmoplastic small round cell tumors. J Pediatr Surg. 2005;40(1):251–255. doi:10.1016/j.jpedsurg.2004.09.046
   PubMed Web of Science ®Google Scholar
• Kushner BH, La Quaglia MP, Wollner N, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996;14(5):1526–1531. doi:10.1200/JCO.1996.14.5.1526
   PubMed Web of Science ®Google Scholar
• Atallah V, Honore C, Orbach D, et al. Role of Adjuvant Radiation Therapy After Surgery for Abdominal Desmoplastic Small Round Cell Tumors. Int J Radiat Oncol Biol Phys. 2016;95(4):1244–1253. doi:10.1016/j.ijrobp.2016.02.046
   PubMed Web of Science ®Google Scholar
• Gedminas JM, Chasse MH, McBrairty M, Beddows I, Kitchen-Goosen SM, Grohar PJ. Desmoplastic small round cell tumor is dependent on the EWS-WT1 transcription factor. Oncogenesis. 2020;9(4):41. doi:10.1038/s41389-020-0224-1
   PubMed Web of Science ®Google Scholar
• Menegaz BA, Cuglievan B, Benson J, et al. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor. Oncologist. 2018;23(3):360–366. doi:10.1634/theoncologist.2017-0408
   PubMed Web of Science ®Google Scholar
• Chen HM, Feng G. Use of anlotinib in intra-abdominal desmoplastic small round cell tumors: a case report and literature review. Onco Targets Ther. 2018;12:57–61. doi:10.2147/OTT.S190333
   PubMed Web of Science ®Google Scholar
• Cheng K, Liu X, Chen Y, Zhou K, Li ZP. Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review. BMC Gastroenterol. 2022;22(1):388. doi:10.1186/s12876-022-02463-y
   PubMed Web of Science ®Google Scholar
• Heuser M. Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment? Hematology Am Soc Hematol Educ Program. 2016;2016(1):24–32. doi:10.1182/asheducation-2016.1.24
   PubMedGoogle Scholar
• Godley LA, Larson RA. Therapy-related myeloid leukemia. Semin Oncol. 2008;35(4):418–429. doi:10.1053/j.seminoncol.2008.04.012
   PubMed Web of Science ®Google Scholar
• Rey G, Daguenet E, Bonjean P, et al. Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC. Bone Marrow Transplant. 2023;58:1331–1338. doi:10.1038/s41409-023-02082-5
   PubMedGoogle Scholar
• Megan EM, Lucy AG, Le Beau MM. Therapy-Related Myeloid Neoplasms: when Genetics and Environment Collide. Nat Rev Cancer. 2017;17(9):513–527. doi:10.1038/nrc.2017.60
   PubMed Web of Science ®Google Scholar
• Sonali M, Michelle M, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102(1):43–52. doi:10.1182/blood-2002-11-3343
   PubMed Web of Science ®Google Scholar
• Dhakal P, Pyakuryal B, Pudasainee P, Rajasurya V, Gundabolu K, Bhatt VR. Treatment Strategies for Therapy-related Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2020;20(3):147–155. doi:10.1016/j.clml.2019.12.007
   PubMed Web of Science ®Google Scholar
• Hart LL, Ferrarotto R, Andric ZG, et al. Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study. Adv Ther. 2021;38:350–365. doi:10.1007/s12325-020-01538-0
   PubMed Web of Science ®Google Scholar